The store will not work correctly when cookies are disabled.
3-(3-benzoyloxy)propoxy-2,6-difluorobenzamide
ID: ALA4068568
PubChem CID: 137632928
Max Phase: Preclinical
Molecular Formula: C17H15F2NO3
Molecular Weight: 319.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1c(F)ccc(OCCCC(=O)c2ccccc2)c1F
Standard InChI: InChI=1S/C17H15F2NO3/c18-12-8-9-14(16(19)15(12)17(20)22)23-10-4-7-13(21)11-5-2-1-3-6-11/h1-3,5-6,8-9H,4,7,10H2,(H2,20,22)
Standard InChI Key: FMTLDLUSNONYDS-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
19.0973 -16.0790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8034 -15.6677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5127 -16.0736 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2188 -15.6624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9241 -16.0700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6298 -15.6595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6271 -14.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9129 -14.4357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2101 -14.8486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4987 -14.4465 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.9069 -13.6185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6116 -13.2047 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1963 -13.2151 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.3327 -14.4292 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.3880 -15.6730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6818 -16.0843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9726 -15.6784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6849 -16.9015 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.9737 -14.8633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2653 -14.4574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5582 -14.8687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5639 -15.6901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2729 -16.0923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
9 10 1 0
8 11 1 0
11 12 1 0
11 13 2 0
7 14 1 0
1 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 319.31 | Molecular Weight (Monoisotopic): 319.1020 | AlogP: 3.11 | #Rotatable Bonds: 7 |
Polar Surface Area: 69.39 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.97 | CX Basic pKa: ┄ | CX LogP: 2.71 | CX LogD: 2.71 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.63 | Np Likeness Score: -0.99 |
References
1. Hu Z, Zhang S, Zhou W, Ma X, Xiang G.. (2017) Synthesis and antibacterial activity of 3-benzylamide derivatives as FtsZ inhibitors., 27 (8): [PMID:28285910] [10.1016/j.bmcl.2017.02.032] |